Aryeh Jason
Reporting owner on Forms 3, 4 and 5, CIK 1376960.
Aryeh Jason reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| LGND · LIGAND PHARMACEUTICALS INCCIK 886163 | director | 3 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-10 | S sold | -500 | $319.99 | 107,976 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-10 | S sold | -844 | $319.995 | 107,132 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-10 | S sold | -646 | $320 | 106,486 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-10 | S sold | -10 | $320.02 | 106,476 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-10 | S sold | -500 | $320.1 | 105,976 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-10 | S sold | -500 | $320.2 | 105,476 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock, holding | 8,000 | Form 4 | ||||
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-04 | S sold | -282 | $319.99 | 108,476 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock, holding | 8,000 | Form 4 | ||||
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-11-02 | S sold | -700 | $320.4261 | 108,758 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-30 | S sold | -50 | $317.74 | 110,819 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-30 | S sold | -50 | $318.23 | 110,769 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-30 | S sold | -52 | $320.24 | 110,717 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-30 | S sold | -1,209 | $320.4172 | 109,508 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock | 2026-10-30 | S sold | -50 | $320.49 | 109,458 | Form 4 |
| LGND · LIGAND PHARMACEUTICALS INCCommon Stock, holding | 8,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001376960-26-000008 | LIGAND PHARMACEUTICALS INC | 2026-11-12 | ||
| Form 4 0001376960-26-000006 | LIGAND PHARMACEUTICALS INC | 2026-11-06 | ||
| Form 4 0001376960-26-000005 | LIGAND PHARMACEUTICALS INC | 2026-11-03 |